Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

Abstract Background The exact risk of developing QTc-prolongation when using a combination of QTc-prolonging drugs is still unknown, making it difficult to interpret these QT drug-drug interactions (QT-DDIs). A tool to identify high-risk patients is needed to support healthcare providers in handling...

Full description

Bibliographic Details
Main Authors: Florine A. Berger, Heleen van der Sijs, Matthijs L. Becker, Teun van Gelder, Patricia M. L. A. van den Bemt
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Medical Informatics and Decision Making
Subjects:
Risk factors
ROC curve
Decision support systems, clinical
Drug interactions
Sensitivity and specificity
Online Access:http://link.springer.com/article/10.1186/s12911-020-01181-3

Internet

http://link.springer.com/article/10.1186/s12911-020-01181-3

Similar Items